BLO:CA:CDX-Cannabix Technologies Inc. (CAD)

COMMON STOCK | Medical Devices | TSX Venture Exchange

Last Closing

USD 0.34

Change

-0.02 (-5.56)%

Market Cap

USD 0.04B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Cannabix Technologies Inc is a technology company. The Company is engaged in developing Cannabix marijuana breathalzer.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-06 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
TLT:CA Theralase Technologies Inc.

-0.01 (-1.61%)

USD 0.07B
PINK:CA Perimeter Medical Imaging AI I..

+0.03 (+6.41%)

USD 0.05B
ASG:CA Aurora Spine Corp

-0.01 (-1.05%)

USD 0.03B
MDX:CA MedX Health Corp

N/A

USD 0.02B
NGMD:CA NuGen Medical Devices Inc

+0.01 (+6.25%)

USD 0.02B
VPT:CA VentriPoint Diagnostics Ltd

N/A

USD 0.02B
THRM:CA Therma Bright Inc

+0.01 (+14.29%)

USD 0.01B
EVMT:CA Evome Medical Technologies Inc..

N/A

USD 0.01B
FREQ:CA Frequency Exchange Corp.

+0.03 (+13.64%)

USD 0.01B
CNVI:CA Conavi Medical Corp.

-0.07 (-9.33%)

N/A

ETFs Containing BLO:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (TSX Venture Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.25% 67% D+ 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.25% 67% D+ 41% F
Trailing 12 Months  
Capital Gain 36.00% 75% C 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 36.00% 75% C 77% C+
Trailing 5 Years  
Capital Gain -51.43% 100% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -51.43% 100% F 53% F
Average Annual (5 Year Horizon)  
Capital Gain 18.99% 100% F 78% C+
Dividend Return 18.99% 100% F 78% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 87.49% 50% F 27% F
Risk Adjusted Return 21.70% 100% F 79% B-
Market Capitalization 0.04B 100% F 93% A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.